PATENT CLAIM ANALYSIS

Application Number: 16184466
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "093200"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.

Claim (Index 4):
The AADC polynucleotide of  claim 3 , wherein one or more of the 5\u2032 ITRs are located 5\u2032 to the MCS region and one or more of the 3\u2032 ITRs are located 3\u2032 to the poly(A) signal.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 98.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524986', '16302146', '15191357', '15209363', '13647155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6876815751980008
- 35 USC 102 Novelty (BERT): 0.5069174748461241
- Combined Prediction Score: 0.6696051651628132
- Mean Citation Score: 233.923604
- Max Citation Score: 283.63107
- Similarity Product: 225.0652286495519

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test